NasdaqCM - Delayed Quote USD
Acasti Pharma Inc. (ACST)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:09 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Operating Cash Flow
-9,689.0000
-12,333.0000
-15,913.0000
-17,234.0000
-14,319.0000
--
Investing Cash Flow
89.0000
104.0000
13,153.0000
-3,522.0000
-9,858.0000
--
Financing Cash Flow
--
7,359.0000
304.0000
--
59,490.0000
--
End Cash Position
19,392.0000
23,005.0000
27,875.0000
30,339.0000
50,942.0000
--
Capital Expenditure
--
-22.0000
-17.0000
--
-69.0000
-319.0000
Issuance of Capital Stock
--
7,338.0000
304.0000
--
59,332.0000
--
Repayment of Debt
-1,556.0000
--
--
--
--
-1,556.0000
Free Cash Flow
-9,711.0000
-12,355.0000
-15,930.0000
-17,234.0000
-14,388.0000
--
3/31/2020 - 2/7/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYCN Cyclerion Therapeutics, Inc.
2.5000
-5.66%
OGEN Oragenics, Inc.
0.3260
+0.34%
ENTX Entera Bio Ltd.
1.8500
+1.09%
VYNE VYNE Therapeutics Inc.
2.2150
+1.14%
ITRM Iterum Therapeutics plc
1.1700
+7.34%
ADXS Ayala Pharmaceuticals, Inc.
0.0270
0.00%
IBIO iBio, Inc.
2.8700
+0.70%
CARA Cara Therapeutics, Inc.
0.2651
-0.64%
SPRB Spruce Biosciences, Inc.
0.5190
+1.76%
KTTA Pasithea Therapeutics Corp.
4.3200
+8.27%